Modified docetaxel and cisplatin in combination with capecitabine (DCX) as first-line treatment in HER2-negative advanced gastric cancer.
Ahmet Bilici
No relevant relationships to disclose
Fatih Selcukbiricik
No relevant relationships to disclose
Nazan Demir
No relevant relationships to disclose
Bala Basak Oven Ustaalioglu
No relevant relationships to disclose
Mustafa Dikilitas
No relevant relationships to disclose
Ozcan Yildiz
No relevant relationships to disclose